Skip to Content

SEC Filings

Filing date	Form	Description	View
Aug 16, 2019	PRER14A	Proxy soliciting materials. Revised preliminary material	0001193125-19-223588.pdf 0001193125-19-223588.rtf 0001193125-19-223588.xls View HTML
Aug 13, 2019	PRRN14A	Non-management revised preliminary proxy soliciting materials	0000921895-19-002191.pdf 0000921895-19-002191.rtf 0000921895-19-002191.xls View HTML
Aug 06, 2019	PREC14A	Preliminary proxy statement containing contested solicitations	0000921895-19-002103.pdf 0000921895-19-002103.rtf 0000921895-19-002103.xls View HTML
Aug 05, 2019	PREC14A	Preliminary proxy statement containing contested solicitations	0001193125-19-213083.pdf 0001193125-19-213083.rtf 0001193125-19-213083.xls View HTML
Jul 26, 2019	8-K	Report of unscheduled material events or corporate event	0001193125-19-204007.pdf 0001193125-19-204007.rtf 0001193125-19-204007.xls View HTML
Jul 25, 2019	3	Initial filing by director officer or owner of more than ten percent.	0000921895-19-002049.pdf 0000921895-19-002049.rtf View HTML
Jul 24, 2019	SC 13D/A	An amendment to a SC 13D filing	0000921895-19-002039.pdf 0000921895-19-002039.rtf 0000921895-19-002039.xls View HTML
Jul 18, 2019	4	Statement of changes in beneficial ownership of securities	0000921895-19-002020.pdf 0000921895-19-002020.rtf View HTML
Jul 17, 2019	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001564590-19-025092.pdf 0001564590-19-025092.rtf 0001564590-19-025092.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
Jul 17, 2019	8-K	Report of unscheduled material events or corporate event	0001193125-19-195208.pdf 0001193125-19-195208.rtf 0001193125-19-195208.xls View HTML

Data provided by Kaleidoscope.

Back to top

Merrimack Pharmaceuticals, Inc.
One Broadway, 14th floor
Cambridge, MA 02142
617-720-8606
info@merrimack.com

© 2021 Merrimack Pharmaceuticals.